I now have rich, detailed content from multiple authoritative textbooks. Let me compile the comprehensive response.
Pathophysiology of Enteric Fever - Detailed Overview
Enteric fever is a systemic illness caused by Salmonella enterica serotype Typhi (S. Typhi) and, to a lesser extent, S. Paratyphi A, B, and C. The term "enteric fever" was proposed in 1869 to distinguish it from typhus based on its anatomical site of infection - the gut-associated lymphoid tissue. The pathophysiology unfolds in distinct, overlapping phases.
1. Inoculum and Gastric Passage
The infectious dose of S. Typhi is relatively small (as few as 10^3 to 10^6 organisms). After ingestion via contaminated food or water:
- S. Typhi is resistant to gastric acid, unlike most gram-negative enteric bacteria, allowing it to survive the stomach environment and reach the small intestine.
- Reduced gastric acidity (from antacid use, H. pylori-induced atrophic gastritis, or malnutrition) significantly lowers the infectious threshold and facilitates infection.
2. Intestinal Entry via M Cells (Week 1 - Incubation Phase)
Once in the terminal ileum, S. Typhi exploits a specialized portal of entry:
- The bacteria preferentially invade M cells (microfold cells) - the specialized antigen-sampling epithelial cells that overlie Peyer's patches in the terminal ileum.
- Unlike S. Enteritidis (which triggers frank enterocolitis), S. Typhi passes through M cells largely without causing immediate inflammatory diarrhea, enabling silent transepithelial migration.
- After crossing the epithelium, bacteria are engulfed by subepithelial macrophages within the lamina propria of Peyer's patches.
This uptake is the critical step that distinguishes S. Typhi from non-typhoidal Salmonella - rather than being killed, S. Typhi survives and replicates inside macrophages.
3. Intracellular Survival and the Salmonella-Containing Vacuole
S. Typhi has evolved multiple mechanisms to resist macrophage killing:
- Vi (virulence) antigen: A polysaccharide capsule unique to S. Typhi that inhibits complement activation and opsonization, and dampens the oxidative burst of phagocytes.
- Salmonella Pathogenicity Islands (SPI-1 and SPI-2): SPI-2 encodes a Type III Secretion System (T3SS) that injects bacterial effector proteins into the macrophage, preventing phagosome-lysosome fusion and creating a protected intracellular replication niche - the Salmonella-containing vacuole (SCV).
- Inside the SCV, bacteria actively replicate and suppress host innate immune signaling.
4. Primary Bacteremia and Seeding of the Reticuloendothelial System (End of Week 1)
After replication in Peyer's patches, bacteria spread via lymphatics to mesenteric lymph nodes, then drain into the thoracic duct and enter the bloodstream:
- This produces a primary, low-grade bacteremia - often subclinical, corresponding to the incubation period (mean 10-14 days; range 5-21 days depending on inoculum size and host immunity).
- Bacteria-laden macrophages disseminate haematogenously to the liver, spleen, and bone marrow - the organs of the reticuloendothelial system (RES).
- In the spleen: the red pulp expands due to prominent phagocyte hyperplasia, with obliteration of follicular markings.
- In the liver: small foci of parenchymal necrosis appear in which hepatocytes are replaced by macrophage aggregates - the so-called "typhoid nodules" (typhoid hepatitis). These nodules are also found in the bone marrow and lymph nodes.
- Bacteria continue to replicate intracellularly throughout the RES during this phase.
5. Secondary Bacteremia and Sustained Fever (Week 1-2)
After replication in the liver, spleen, and bone marrow, a secondary, high-grade bacteremia erupts into the bloodstream - this is the phase that corresponds to the onset of clinical fever and systemic symptoms:
- Fever is typically 39-40.5°C (103-105°F), rising in a characteristic stepwise fashion over the first 3-5 days before becoming sustained.
- The fever is driven by lipopolysaccharide (LPS/endotoxin) of S. Typhi, which stimulates macrophages to release pyrogenic cytokines: IL-1β, TNF-α, and IL-6 - these act on the hypothalamus to raise the thermoregulatory set-point.
- Relative bradycardia (Faget's sign): A slow pulse despite high fever is a pathognomonic feature. This paradoxical response is thought to be related to endotoxin-mediated cardiac effects or direct myocardial involvement.
During bacteremia, organisms colonize the gallbladder - a critical step in the disease cycle. S. Typhi forms biofilms on gallstones and invades gallbladder epithelial cells, establishing a reservoir.
6. Intestinal Re-Seeding and Peyer's Patch Necrosis (Week 2-3)
From the bile-colonized gallbladder, S. Typhi is re-excreted into the intestinal lumen via the bile duct. This reseeding of the gut triggers the most significant intestinal pathology:
- Peyer's patches, already primed from initial bacterial contact, mount a massive immune response - hyperplasia and infiltration by macrophages, lymphocytes, neutrophils, and plasma cells.
- Peyer's patches in the terminal ileum enlarge into sharply demarcated, plateau-like elevations up to 8 cm in diameter.
- Progressive ischemia and inflammation lead to mucosal shedding, creating oval ulcers oriented longitudinally along the long axis of the ileum (parallel to the bowel's axis - distinguishing typhoid ulcers from transverse ulcers of TB).
- The mesenteric lymph nodes also enlarge substantially due to reactive hyperplasia and accumulation of bacteria-laden phagocytes.
This is why the classic Widal response corresponds to: Peyer's patch hyperplasia → necrosis → ulceration.
The natural history of culture positivity and antibody response over time is shown below:
FIGURE: Natural history of typhoid fever without antimicrobial therapy. Note the peak blood culture positivity at weeks 1-2, stool culture positivity throughout, and the late rise in agglutinating antibody. (Sherris & Ryan's Medical Microbiology, 8th ed.)
7. Systemic Inflammatory Response and Organ Involvement
The sustained bacteremia with endotoxemia drives multi-organ effects:
Liver
- Hepatomegaly in ~50% of patients; elevated liver enzymes
- Typhoid nodules (focal macrophage aggregates replacing hepatocytes)
- Occasionally frank hepatitis or hepatic abscess
Spleen
- Splenomegaly in ~50%; spleen is soft and congested due to red pulp expansion
- Risk of spontaneous splenic rupture (rare but catastrophic)
Skin - "Rose Spots"
- Appear in ~30% of patients at the end of week 1 to week 2, primarily on the trunk/chest
- Salmon-colored, blanching, maculopapular lesions - 2-4 mm
- Represent foci of bacterial emboli within skin capillaries, with surrounding macrophage infiltration
- S. Typhi can be cultured from punch biopsies of these lesions
- More difficult to visualize in patients with darker skin
FIGURE: "Rose spots," the rash of enteric fever. (Harrison's Principles of Internal Medicine, 22nd ed.)
Central Nervous System
- Neurologic manifestations in 2-40% of patients
- "Muttering delirium" or "coma vigil" (typhoid encephalopathy) - picking at bedclothes or imaginary objects
- Meningitis, Guillain-Barré syndrome, neuritis, seizures
- Mechanism: endotoxemia, direct bacterial invasion, and cytokine-mediated neuroinflammation
Bone Marrow
- Hyperplasia with macrophage infiltration; typhoid nodules
- Leukopenia and neutropenia (in ~20% of patients) - likely due to bone marrow suppression and splenic sequestration
- Thrombocytopenia may occur, contributing to hemorrhagic complications
8. Complications (Week 3-4 and Beyond)
Complications occur in ~27% of hospitalized patients, correlating with delayed treatment.
Intestinal Perforation (1-5%)
- Results from full-thickness necrosis of Peyer's patches in the terminal ileum/proximal colon
- Typically occurs in the 3rd to 4th week of untreated illness
- Perforation is typically on the antimesenteric border within 30 cm of the ileocecal valve
- Leads to peritonitis - a life-threatening surgical emergency
Intraoperative view of typhoid intestinal perforation: oval defect on the antimesenteric border of the terminal ileum, with necrotic edges - the pathognomonic finding of Salmonella Typhi-related Peyer's patch necrosis.
Gastrointestinal Hemorrhage (6%)
- Ulcer erosion into mesenteric vessels
- More common than perforation; presents with melena or hematochezia
Disseminated Intravascular Coagulation (DIC)
- Endotoxin activates the coagulation cascade
- Presents with bleeding tendency, petechiae, and organ ischemia
Other Metastatic Infections
- Biliary tree: gallbladder infection → chronic carrier state (2-5% of patients; reservoir in gallbladder biofilms on stones)
- Bone and joints: osteomyelitis (especially in sickle cell disease patients)
- Meninges: bacterial meningitis
- Heart: endocarditis, myocarditis, pericarditis
- Lungs: pneumonia
- Urinary tract: pyelonephritis, glomerulonephritis
9. Chronic Carrier State
- 2-5% of patients develop chronic asymptomatic carriage (shedding S. Typhi in stool or urine for >1 year)
- The gallbladder is the primary reservoir - bacteria persist by:
- Forming biofilms on gallstones
- Invading gallbladder epithelial cells
- Risk factors for chronic carriage: female sex, infants, biliary abnormalities, concurrent Schistosoma haematobium bladder infection
- Chronic carriers have an increased risk of gallbladder cancer
10. Immune Response and Resolution
- Cell-mediated immunity (macrophage activation by IFN-γ from T cells) is the primary defense
- Specific IgM antibodies against O and H antigens rise by week 2-3 (basis of the Widal test)
- In uncomplicated untreated cases, illness gradually resolves by the end of week 4
- Relapse occurs in up to 10% of patients, typically 2-3 weeks after defervescence, with the same strain - caused by residual intracellular bacteria that were not completely eradicated
Summary Flowchart of Pathogenesis
Ingestion of S. Typhi
↓
Acid resistance → Survival in stomach
↓
Invasion via M cells in terminal ileum
↓
Engulfed by macrophages in Peyer's patches
↓ [Vi antigen + SPI-2 T3SS prevent killing]
Intracellular replication in SCV
↓
Lymphatic spread → Mesenteric LN → Thoracic duct
↓
PRIMARY BACTEREMIA (silent, incubation period ~10-14 days)
↓
Seeding of liver, spleen, bone marrow (RES)
↓
Replication → SECONDARY BACTEREMIA
↓
Sustained fever (stepwise rise, then plateau), rose spots,
hepatosplenomegaly, relative bradycardia
↓
Gallbladder colonization → biliary re-excretion into gut
↓
Peyer's patch hyperplasia → ulceration → necrosis
↓
Complications: perforation, hemorrhage, DIC, metastatic foci
↓
Resolution (week 4) or Chronic carrier state
Sources:
- Harrison's Principles of Internal Medicine, 22nd ed. (2025) - Chapter 171, pp. 1359-1361
- Goldman-Cecil Medicine, International Ed. - Salmonella Infections (Enteric Fever)
- Robbins & Kumar Basic Pathology and Robbins, Cotran & Kumar Pathologic Basis of Disease - GI Infections chapters
- Sherris & Ryan's Medical Microbiology, 8th ed. - Chapter 33, p. 1325
- Medical Microbiology, 9th ed. - Chapter 25